Allelic imbalance analysis using a single-nucleotide polymorphism microarray for the detection of bladder cancer recurrence

Clinical Cancer Research

Volumn 14, Issue 24, 2008, Pages 8198-8204

  Coenen, Mariekej H ^a   Ploeg, Martine ^b   Schijvenaars, Mascha M V A P ^a   Cornel, Erik B ^f   Karthaus, Herbert F M ^d   Scheffer, Hans ^a   Witjes, J Alfred ^b   Franke, Barbara ^a   Kiemeney, Lambertus A L M ^b,c,e  

^a Departments of Human Genetics   (Netherlands)

^b Urology   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e Integraal Kankercentrum Oost   (Netherlands)

^f Hospital Group Twente   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELIC IMBALANCE; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; FOLLOW UP; GENE LOCUS; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; URINALYSIS; BLADDER TUMOR; DNA MICROARRAY; GENE DOSAGE; GENETICS; METHODOLOGY; ROC CURVE; TUMOR RECURRENCE;

ALLELIC IMBALANCE; GENE DOSAGE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 58149356742     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1103     Document Type: Article

References (38)

1. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-95.
2. Heney NM. Natural history of superficial bladder cancer. Prognosticfeatures and long-term disease course. Urol Clin North Am 1992;19:429-33.
3. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49:466-5.
4. Schmidbauer J, Witjes F, Schmeller N, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135 -8.
5. Koss LG. Errors and pitfalls in cytology of the lower urinary tract. Monogr Pathol 1997;39:60-74.
6. Brown FM. Urine cytology. It is still the gold standard for screening? Urol Clin North Am 2000;27:25-37.
7. Sherman AB, Koss LG, Adams SE. Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal Quant Cytol 1984;6:112-20.
8. Glas AS, Roos D, Deutekom M, et al. Tumor markers in the diagnosis of primary bladder cancer. A systematic review. J Urol 2003;169:1975 -82.
9. Lotan Y, Roehrborn CG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 2003;61:109 -18.
10. Orntoft TF, Wolf H. Molecular alterations in bladder cancer. Urol Res1998;26:223 -33.
11. Cordon-Cardo C. Molecular alterations in bladder cancer. Cancer Surv1998;32:115 -31.
12. Koed K, Wiuf C, Christensen LL, et al. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Res 2005;65:34-45.
13. Hoque MO, Lee CC, Cairns P, Schoenberg M, Sidransky D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res 2003;63:2216-22.
14. Primdahl H, Wikman FP, von der MH, et al. Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J Natl Cancer Inst 2002;94:216 -23.
15. Hoque MO, Lee J, Begum S, et al. High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. Cancer Res 2003;63:5723-6.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res1988;16:1215.
17. Matsuzaki H, Loi H, Dong S, et al. Parallel genotyp-ing ofover10,000SNPsusing a one-primerassayon a high-density oligonucleotide array. Genome Res 2004;14:414-25.
18. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005;65: 6071 -9.
19. George RE, Attiyeh EF, Li S, et al. Genome-wideanal-ysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS ONE 2007;2:e255.
20. Harada T, Chelala C, Bhakta V, et al. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 2008;27:1951 -60.
21. Reznikoff CA, Sarkar S, Julicher KP, et al. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 2000;5:191 -203.
22. Kimura F, Florl AR, Seifert HH, et al. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. BrJ Cancer 2001;85:1887-93.
23. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003;63:2872 -80.
24. Cheng L, MacLennan GT, Zhang S, et al. Lasercapture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101:183-8.
25. Migaldi M, Sartori G, Rossi G, et al. Prevalence and prognostic significance of microsatellite alterations in young patients with bladder cancer. Mod Pathol 2005;18:1176-86.
26. Hurst CD, Fiegler H, Carr P, et al. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004;23:2250-63.
27. Blaveri E, Brewer JL, Roydasgupta R, et al. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 2005;11:7012-22.
28. Vaish M, Mandhani A, Mittal RD, Mittal B. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance. BMC Urol 2005;5:2.
29. Obermann EC, Junker K, Stoehr R, et al. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. J Pathol 2003;199:50-7.
30. Berger AP, Parson W, Stenzl A, et al. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. Eur Urol 2002;41:532 -9.
31. Szarvas T, Kovalszky I, Bedi K, et al. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. Oncol Rep 2007;18:405 -9.
32. Frigerio S, Padberg BC, Strebel RT, et al. Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis. Int J Cancer 2007;121:329-38.
33. Junker K, Kania K, Fiedler W, et al. Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. Int J Oncol 2002;20:647 -53.
34. Hartmann A, Moser K, Kriegmair M, et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154:721 -7.
35. Muto S, Horie S, Takahashi S, Tomita K, KitamuraT. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. Cancer Res 2000;60:4021 -5.
36. Stoehr R, Zietz S, Burger M, et al. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol 2005;47:58-63.
37. Mazzucchelli R, Barbisan F, Stramazzotti D, et al. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features. Anal Quant Cytol Histol 2005; 27:143-51.
38. Junker K, Boerner D, Schulze W, et al. Analysis of genetic alterations in normal bladder urothelium. Urology 2003;62:1134-8.